A Real-World, Multicenter, 6-Month Prospective Study in Greece of the Effectiveness and Safety of Ranibizumab in Patients with Age-Related Macular Degeneration Who Have Inadequately Responded to Aflibercept: The “ELEVATE” Study

A Real-World, Multicenter, 6-Month Prospective Study in Greece of the Effectiveness and Safety of Ranibizumab in Patients with Age-Related Macular Degeneration Who Have Inadequately Responded to Aflibercept: The “ELEVATE” Study

Alexandros Rouvas,1 Ioannis Datseris,2 Sofia Androudi,3 Miltiadis Tsilimbaris,4 Stamatina A Kabanarou,5 Nikolaos Pharmakakis,6 Chryssanthi Koutsandrea,7 Alexander Charonis,8 Olga Kousidou,9 Georgia Pantelopoulou9 1 2nd Department of Ophthalmology, Attikon Hospital, National and Kapodistrian Universi...

Full description

Bibliographic Details
Main Authors: Rouvas A, Datseris I, Androudi S, Tsilimbaris M, Kabanarou SA, Pharmakakis N, Koutsandrea C, Charonis A, Kousidou O, Pantelopoulou G
Format: Article
Language:English
Published: Dove Medical Press 2022-08-01
Series:Clinical Ophthalmology
Subjects:
best corrected visual acuity
central retinal thickness
pigment epithelial detachment
Online Access:https://www.dovepress.com/a-real-world-multicenter-6-month-prospective-study-in-greece-of-the-ef-peer-reviewed-fulltext-article-OPTH

Internet

https://www.dovepress.com/a-real-world-multicenter-6-month-prospective-study-in-greece-of-the-ef-peer-reviewed-fulltext-article-OPTH

Similar Items